NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News  » Business » Now, a 4-in-1 vaccine from Shanta Biotech

Now, a 4-in-1 vaccine from Shanta Biotech

August 19, 2005 15:50 IST
Shantha Biotechnics Ltd on Friday announced the availability of 'Shantetra', a combination vaccine against diphtheria, tetanus, pertussis and hepatitis-B, claimed to be the first indigenously developed four-in-one immunity shot.

The DTPH vaccine, which protects children against the four life-threatening infections, is available in two presentations -- 0.5 ML and 5 ML -- and can be administered to infants from the sixth week onwards, Varaprasad Reddy, Shanta Biotech managing director said.

Shanta aims to expand its current vaccines portfolio by launching new generation vaccines in the near future keeping in view the global phenomenon of combination vaccines, which is catching up as it reduces the number of injections to be administered to the child, he said.

Company's executive director Khalil Ahmed said Shanta has a reputation of trusted vendor to the supra-national customers such as UNICEF and WHO and its new product 'Shantetra' would capitalize on its reputation built by the flagship product Shanvac-B. 

© Copyright 2018 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.